P2.01-104 Plasma T-Cell-Derived Circulating DNA in Advanced NSCLC is Not Correlated with TIL but has a Potential of Prognostic Value

B. Weerasubpong; C. Vinayanuwattikun; P. Chantranuwatana; V. Sriuranpong

首页> 外文期刊>Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer >P2.01-104 Plasma T-Cell-Derived Circulating DNA in Advanced NSCLC is Not Correlated with TIL but has a Potential of Prognostic Value

【24h】

P2.01-104 Plasma T-Cell-Derived Circulating DNA in Advanced NSCLC is Not Correlated with TIL but has a Potential of Prognostic Value

机译：P2.01-104晚期NSCLC中的血浆T细胞衍生的循环DNA与TIL不相关但具有预后值的潜力

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共1页
作者
B. Weerasubpong; C. Vinayanuwattikun; P. Chantranuwatana; V. Sriuranpong;
展开▼
作者单位

Faculty of Medicine Chulalongkorn University;

Faculty of Medicine Chulalongkorn University;

Pathology Chulalongkorn University;

Faculty of Medicine Chulalongkorn University;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. P2.01-104 Plasma T-Cell-Derived Circulating DNA in Advanced NSCLC is Not Correlated with TIL but has a Potential of Prognostic Value [J] . B. Weerasubpong, C. Vinayanuwattikun, P. Chantranuwatana, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2018,第10期

机译：P2.01-104晚期NSCLC中的血浆T细胞衍生的循环DNA与TIL不相关但具有预后值的潜力
2. 6569 POSTER The quantification of plasmatic free DNA is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients [J] . C.Camps, R.Sirera, R.M.Bremnes, European Journal of Cancer Supplements . 2007,第4期

机译：6569海报血浆游离DNA的定量是晚期非小细胞肺癌（NSCLC）患者的预后因素
3. P1.01-024 Plasma Circulating cfDNA as a Potential Biomarker in Clinical Management of NSCLC: Experience of Tata Memorial Hospital, India [J] . A. Choughule, K. Prabhash, V. Naronha, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P1.01-024等离子体循环CFDNA作为NSCLC临床管理中的潜在生物标志物：印度塔塔纪念医院的经验
4. Direct characterization of circulating DNA in blood plasma using μLAS technology [C] . R. Malbec, B. Chami, H. H. T. Ngo, IEEE International Electron Devices Meeting . 2017

机译：使用μLAS技术直接表征血浆中循环DNA
5. Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer. [D] . Gonzales, Jason Cadaoas. 2010

机译：癌症中新型生物标志物的开发：检测循环miR-141作为前列腺癌的潜在预后标志物。
6. The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing [O] . Chuangzhou Rao, Liangqin Nie, Xiaobo Miao, 2018

机译：基于循环肿瘤DNA测序的中国晚期NSCLC患者的临床特征及预后分析
7. The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing [O] . Chuangzhou Rao, Liangqin Nie, Xiaobo Miao, 2018

机译：基于循环肿瘤DNA测序的中国先进NSCLC患者的临床特征及预后分析

P2.01-104 Plasma T-Cell-Derived Circulating DNA in Advanced NSCLC is Not Correlated with TIL but has a Potential of Prognostic Value

著录项

相似文献

相关主题

期刊订阅